T. Rowe Price Associates’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $128K | Sell |
|
|||||
|
2021
Q2 | $178K | Sell |
|
|||||
|
2021
Q1 | $306K | Hold |
|
|||||
|
2020
Q4 | $276K | Hold |
|
|||||
|
2020
Q3 | $262K | Sell |
|
|||||
|
2020
Q2 | $216K | Sell |
|
|||||
|
2020
Q1 | $248K | Buy |
|
|||||
|
2019
Q4 | $261K | Buy |
|
|||||
|
2019
Q3 | $301K | Buy |
|
|||||
|
2019
Q2 | $365K | Buy |
|
|||||
|
2019
Q1 | $90K | Buy |
|
|||||
|
2018
Q4 | $107K | Sell |
|
|||||
|
2018
Q3 | $334K | Buy |
|
|||||
|
2018
Q2 | $427K | Buy |
|